National Institutes of Health (NIH)…
If you want to know if National Institutes of Health (NIH)… is credible or reliable, look no further. We rank National Institutes of Health (NIH)… as high factuality. Find out more about our methodology here.
Information about National Institutes of Health (NIH)…Where is National Institutes of Health (NIH)… located?Washington, United StatesNational Institutes of Health (NIH)…'s WebsiteNational Institutes of Health (NIH)…'s TwitterNational Institutes of Health (NIH)…'s Wikipedia
Ownership
Who owns National Institutes of Health (NIH)…?Government: United States Department of Health and Human Services
Learn more about Ownership categories.
Factuality
How credible is the news from National Institutes of Health (NIH)…?Learn more about Factuality Ratings.
Media Bias Ratings
Does National Institutes of Health (NIH)… lean left or right?
Learn more about Media Bias Ratings.
Top National Institutes of Health (NIH)… News
Latest News Stories
Research · New BrunswickJohnson & Johnson’s JNJ, -1.51% experimental HIV vaccine is safe but not effective, and the late-stage study will be discontinued as a result of that finding, federal researchers said Wednesday.
Experimental HIV vaccine regimen safe but ineffective, NIH study finds
56% Center coverage: 9 sources
Europe · New YorkYou may know that being adequately hydrated is important for day-to-day bodily functions such as regulating temperature and maintaining skin health.But drinking enough water is also associated with a significantly lower risk of developing chronic diseases, a lower risk of dying early or lower risk of being biologically older than your chronological age, according to a National Institutes of Health study published Monday in the journal eBioMedicine.
Staying hydrated is linked to lower disease risk, lower risk of dying early, study finds
85% Center coverage: 58 sources
US & Canada · WashingtonThe National Institutes of Health has initiated a multi-site clinical trial evaluating an investigational antiviral for the treatment of COVID-19.
NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19
50% Center coverage: 4 sources
Business · WashingtonThe U.S. National Institutes of Health (NIH) on Thursday launched a virtual program aimed at making antiviral treatments for COVID-19 available at home for those who test positive.
NIH launches pilot COVID telehealth program
38% Left coverage: 8 sources
Environment · New YorkModerate levels of two outdoor air pollutants, ozone and fine particulate matter, are associated with non-viral asthma attacks in children and adolescents who live in low-income urban areas, a study has found. The study also identifies associations between exposure to the two pollutants and molecular changes in the children's airways during non-viral asthma attacks, suggesting potential mechanisms for those attacks. The observational study is on…
Air pollutants in low-income urban areas linked with youth asthma attacks: study
75% Center coverage: 4 sources
TechA clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system. The Phase 1 trial was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. A non-temperature stable form of the candidate previously had been tested in
Temperature-stable tuberculosis vaccine safe, prompts immune response in first-in-human trial
50% Center coverage: 4 sources
Africa · MarburgA paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID), could someday be an important tool to respond to MARV outbreaks. MARV is a filovirus in the same family as Ebola virus.
Experimental vaccine against Marburg virus shows promise in first-in-human clinical trial
60% Center coverage: 5 sources
FDAThe immunotherapy drug atezolizumab (Tecentriq) was recently approved by the U.S. Food and Drug Administration. About 80 people in the United States are diagnosed with ASPS every year. About a third of patients responded to the treatment with some degree of tumor shrinkage.
NCI-led clinical trial results in the first approval of a treatment for advanced alveolar soft part sarcoma
67% Center coverage: 3 sources
